
Publikationen von Amelie Heuer-Jungemann
Alle Typen
Zeitschriftenartikel (12)
1.
Zeitschriftenartikel
16 (1), 1556 (2025)
Fully addressable designer superstructures assembled from one single modular DNA origami. Nature Communications 2.
Zeitschriftenartikel
64 (3), e202416948 (2025)
Crystalline Assemblies of DNA Nanostructures and their Functional Properties. Angewandte Chemie International Edition 3.
Zeitschriftenartikel
19 (10), S. 1521 - 1531 (2024)
A modular DNA origami nanocompartment for engineering a cell-free, protein unfolding and degradation pathway. Nature Nanotechnology 4.
Zeitschriftenartikel
36 (39), 2405104 (2024)
Compliant DNA origami nanoactuators as size-selective nanopores. Advanced Materials 5.
Zeitschriftenartikel
20 (24), 2309680 (2024)
Protein-assisted large-scale assembly and differential patterning of DNA origami lattices. Small 6.
Zeitschriftenartikel
35 (23), 2212024 (2023)
Full site-specific addressability in DNA origami-templated silica nanostructures. Advanced Materials 7.
Zeitschriftenartikel
8 (20), S. 18225 - 18233 (2023)
Lyophilization Reduces Aggregation of Three-Dimensional DNA Origami at High Concentrations. ACS Omega 8.
Zeitschriftenartikel
50 (7–10), S. 1243 - 1251 (2023)
Luminescent DNA-origami nano-rods dispersed in a lyotropic chromonic liquid crystal. Liquid Crystals 9.
Zeitschriftenartikel
13 (1), 5668 (2022)
In situ small-angle X-ray scattering reveals strong condensation of DNA origami during silicification. Nature Communications 10.
Zeitschriftenartikel
17 (26), 2101678 (2021)
Nanoscale FasL Organization on DNA Origami to Decipher Apoptosis Signal Activation in Cells. Small 11.
Zeitschriftenartikel
7 (12), S. 1969 - 1979 (2021)
Engineering Inorganic Materials with DNA Nanostructures. ACS Central Science 12.
Zeitschriftenartikel
49 (6), S. 3048 - 3062 (2021)
Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release. Nucleic Acids Research Preprint (1)
13.
Preprint
High yield purification of an Isoleucine zipper modified CD95 Ligand with either biotin or DNA-oligomer binding domain for efficient Cell Apoptosis Induction. bioRxiv (2024)